
QS-21 Human Vaccine Adjuvant
- Used in 5 globally approved vaccines
- 200–400 million human doses annually
- EXCiPACT & IPEC GMP certified quality
GMP Certified
EXCiPACT Certified
FSC Certified
QS-21 Adjuvant is one of the world's most potent immunological adjuvants, derived from Quillaja saponaria bark. Used in 5 globally approved vaccines including Shingrix and Arexvy, it simultaneously enhances antibody production and cellular immunity. Available through VuRoyal Pharmaceutical, the exclusive China distributor for Desert King International, with GMP-certified, EXCiPACT-certified supply.





Talk to our product experts for custom solutions.
Apply Filters





QS-21 is a highly purified saponin adjuvant extracted from the bark of the Quillaja saponaria Molina (Chilean soapbark) tree. With a molecular weight of 1990 Da and classified as an acylated triterpene glycoside, it is isolated via reverse-phase HPLC and produced to GMP pharmaceutical-grade standards at certified facilities in Chile, Mexico, and Italy.
Talk to our experts for custom solutions and tailored guidance.

QS-21 enhances antibody and cellular immunity in approved vaccines for shingles, RSV, malaria, and COVID-19.

Used in Phase I–III trials for HIV, cancer, Alzheimer's, hepatitis B, and over 20 investigational vaccine candidates.

QA-21 and Vet-sap adjuvants improve immune response in poultry, swine, aquaculture, and ruminant vaccine programs.

End-to-end supply of QS-21 and reference listed drugs to hospitals, pharmacies, and trial sponsors via compliant cold chain logistics.
Talk to our experts for custom solutions and tailored guidance.
As Desert King International's sole authorized China partner since 2023, VuRoyal provides direct, verified access to GMP-grade QS-21 adjuvant with full supply chain transparency from forest to final product.
From imported drug approval registration and customs clearance to cold chain transportation, VuRoyal delivers compliant, door-to-door pharmaceutical supply chain solutions with free regulatory guidance included.
VuRoyal's founders bring decades of pharmaceutical R&D and clinical research experience, ensuring expert technical consultation, adjuvant application guidance, and reliable supply for complex vaccine development programs.
Submit your inquiry and our specialists will respond with pricing, regulatory guidance, and supply chain options tailored to your research or production needs.
For immediate assistance, feel free to give us a direct call at +1 617-870-2690.
For immediate assistance, feel free to give us a direct call at +1 617-870-2690.